Metsera Inc (MTSR) Stock Price, Quote & News - Mboum

Company Profile

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, N...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 784 6595

Website: metsera.com

Address:

3 World Trade Center, 175 Greenwich Street, New York, United States

himsssss Jun. 30 at 9:03 PM

$MTSR 28 week data coming soon.

0 · Reply

judgeyoung2 Jun. 25 at 3:40 PM

$VKTX anyone know why metsera is down? $MTSR

2 · Reply

judgeyoung2 Jun. 24 at 4:03 AM

$MTSR so data should be by end of this week?

0 · Reply

bavariaron Jun. 23 at 11:04 PM

$VKTX ** Big Pharma Needs to Beef up M&A ** https://youtu.be/ohGp7H3S0xM?si=Iy1swg7oLgrQHH3h $TERN $GPCR $MTSR

3 · Reply

judgeyoung2 Jun. 23 at 10:42 PM

0 · Reply

frontiere Jun. 23 at 12:08 PM

$HIMS HIMS tiny short from $54 — on news of $NVO Novo Nordisk terminating their collab — likely down to <$20 eventually, as it’s a pump. NVO possibly prepping to litigate against HIMS . Cc $LLY Eli Lilly (holding big short from higher) $VKTX Viking $MTSR Metsera etc

1 · Reply

Theflash88 Jun. 20 at 6:18 PM

$MTSR That’s more like it!

0 · Reply

IN0V8 Jun. 20 at 3:05 PM

$MTSR Buy Wells Fargo initiates coverage with overweight rating Wells Fargo initiates coverage with target price $65

0 · Reply

himsssss Jun. 20 at 1:06 PM

0 · Reply

JarvisFlow Jun. 20 at 12:00 PM

Wells Fargo has adjusted their stance on Metsera ( $MTSR ), setting the rating to Overweight with a target price of 65.

0 · Reply

Latest News on MTSR

Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Jun 10, 2025, 7:00 AM EDT - 21 days ago

Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Metsera Stock Rises As Company Advances Obesity Pipeline With Encouraging Weight Loss Data

Jun 9, 2025, 2:07 PM EDT - 21 days ago

Metsera Stock Rises As Company Advances Obesity Pipeline With Encouraging Weight Loss Data

Metsera rises as experimental weight-loss drug shows promise in small early-stage trial

Jun 9, 2025, 12:04 PM EDT - 21 days ago

Metsera rises as experimental weight-loss drug shows promise in small early-stage trial

Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i

Jun 9, 2025, 7:00 AM EDT - 22 days ago

Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i

Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®

Jun 5, 2025, 7:30 AM EDT - 26 days ago

Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress

May 12, 2025, 7:00 AM EDT - 7 weeks ago

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress

Metsera to Present at Bank of America 2025 Global Healthcare Conference

May 8, 2025, 4:01 PM EDT - 7 weeks ago

Metsera to Present at Bank of America 2025 Global Healthcare Conference

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

Mar 26, 2025, 7:00 AM EDT - 3 months ago

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

Metsera to Present at TD Cowen's 45th Annual Health Care Conference

Feb 26, 2025, 7:00 AM EST - 4 months ago

Metsera to Present at TD Cowen's 45th Annual Health Care Conference

Metsera: Capturing Of Obesity Market With Long-Acting GLP-1 Differentiation

Feb 26, 2025, 3:55 AM EST - 4 months ago

Metsera: Capturing Of Obesity Market With Long-Acting GLP-1 Differentiation

Why this newly public biotech could become a force in obesity treatments

Feb 25, 2025, 1:42 PM EST - 4 months ago

Why this newly public biotech could become a force in obesity treatments

This weight-loss drug stock could deliver a 90% return in 2025

Feb 25, 2025, 8:47 AM EST - 4 months ago

This weight-loss drug stock could deliver a 90% return in 2025

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters' Option to Purchase Additional Shares

Feb 5, 2025, 4:01 PM EST - 5 months ago

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters' Option to Purchase Additional Shares

U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs

Feb 1, 2025, 2:10 AM EST - 5 months ago

U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs

BBNX CSAI INR MAZE ODTX ODYS SAIL

Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut

Jan 31, 2025, 12:42 PM EST - 5 months ago

Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut

Weight-loss drug developer Metsera raises $275 million in US IPO

Jan 30, 2025, 7:05 PM EST - 5 months ago

Weight-loss drug developer Metsera raises $275 million in US IPO

Metsera Announces Pricing of Initial Public Offering

Jan 30, 2025, 6:53 PM EST - 5 months ago

Metsera Announces Pricing of Initial Public Offering

Metsera Readies $275 Million IPO For Obesity Treatments

Jan 28, 2025, 4:48 PM EST - 5 months ago

Metsera Readies $275 Million IPO For Obesity Treatments

Weight-loss drug developer Metsera reveals wider loss in US IPO filing

Jan 10, 2025, 6:02 PM EST - 6 months ago

Weight-loss drug developer Metsera reveals wider loss in US IPO filing

Metsera IPO Registration Document (S-1)

Jan 10, 2025, 4:46 PM EST - 6 months ago

Metsera IPO Registration Document (S-1)

himsssss Jun. 30 at 9:03 PM

$MTSR 28 week data coming soon.

0 · Reply

judgeyoung2 Jun. 25 at 3:40 PM

$VKTX anyone know why metsera is down? $MTSR

2 · Reply

judgeyoung2 Jun. 24 at 4:03 AM

$MTSR so data should be by end of this week?

0 · Reply

bavariaron Jun. 23 at 11:04 PM

$VKTX ** Big Pharma Needs to Beef up M&A ** https://youtu.be/ohGp7H3S0xM?si=Iy1swg7oLgrQHH3h $TERN $GPCR $MTSR

3 · Reply

judgeyoung2 Jun. 23 at 10:42 PM

0 · Reply

frontiere Jun. 23 at 12:08 PM

$HIMS HIMS tiny short from $54 — on news of $NVO Novo Nordisk terminating their collab — likely down to <$20 eventually, as it’s a pump. NVO possibly prepping to litigate against HIMS . Cc $LLY Eli Lilly (holding big short from higher) $VKTX Viking $MTSR Metsera etc

1 · Reply

Theflash88 Jun. 20 at 6:18 PM

$MTSR That’s more like it!

0 · Reply

IN0V8 Jun. 20 at 3:05 PM

$MTSR Buy Wells Fargo initiates coverage with overweight rating Wells Fargo initiates coverage with target price $65

0 · Reply

himsssss Jun. 20 at 1:06 PM

0 · Reply

JarvisFlow Jun. 20 at 12:00 PM

Wells Fargo has adjusted their stance on Metsera ( $MTSR ), setting the rating to Overweight with a target price of 65.

0 · Reply

theflynews Jun. 20 at 9:10 AM

Metsera initiated with bullish view at Wells Fargo, here's why - $MTSR - https://thefly.com/permalinks/entry.php/MTSRid4147767?1750409773C3

0 · Reply

topstockalerts Jun. 19 at 7:17 PM

$MTSR where’s she going next??🚨🏦🚨

0 · Reply

ChartTwerker Jun. 18 at 3:22 PM

0 · Reply

himsssss Jun. 18 at 2:40 PM

$MTSR let's ride this to $35 again.

1 · Reply

himsssss Jun. 18 at 2:18 PM

$VKTX bought the dip on $MTSR yesterday because we all know how this ends up.

1 · Reply

himsssss Jun. 17 at 4:41 PM

$MTSR building back the position from these levels.

0 · Reply

GuruRanger Jun. 16 at 8:17 PM

$MTSR Is this thinking about closing the $14 gap?

0 · Reply

Theflash88 Jun. 16 at 7:12 PM

$MTSR What happened?

0 · Reply

himsssss Jun. 12 at 8:14 PM

$MTSR $VKTX Bulls watching MTSR out gain every week without a fail.

0 · Reply

himsssss Jun. 12 at 8:11 PM

$MTSR There really isn't anything stopping this from going higher than my short term pt of $35. continuing to hold.

0 · Reply

Gostrongx Jun. 12 at 6:26 PM

$VKTX how is no name $MTSR moving higher with little pipeline and VKTX continues to do nothing?

1 · Reply

trading_momentum Jun. 11 at 3:53 AM

Added 500 $MTSR commons @ 33 this one is 1 yr hold

0 · Reply